Patent · US Active

Polymorphic forms of RAD1901-2HCL

US12398094B2 · kind B2 · utility

0Cited by
126References
16Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 31, 2023
Grant dateAug 26, 2025
Priority date
Expiry dateMay 31, 2043

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07C217/84
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

Various polymorphic forms of RAD1901-2HCl, including three crystalline and amorphous forms, are prepared and characterized. Uses of the various polymorphic forms of RAD1901-2HCl for cancer treatment are also disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.